Medicaid advises states to limit autism therapy billing

Negative4 min readAI-generated summary

Report this article

Tell us what is wrong. We read every report.

Report this article
Medicaid advises states to limit autism therapy billing
Health

The New York Times

The federal Medicaid office will publish a 173-page set of best practices urging states to restrict how autism therapy providers bill Medicaid after spending jumped from about $2 billion in 2021 to $10 billion in 2025. Officials cited faster cost growth than the 67 percent rise in diagnoses, audits showing billing for nontherapeutic activities, and clinics prescribing very long weeks of care, sometimes 40 hours. The guidance recommends prior authorization for high hours, limits on stacked 15-minute billing units, outcome tracking, and scrutiny for clinics that bill maximum hours for most patients, prompting likely state policy changes and legislative action.

Medicaid autism therapy spending rose to $10 billion in 2025.

Context

Medicaid spending on autism therapy rose fivefold since 2021. Investigations and state audits found overbilling and nontherapeutic billing. Federal guidelines will be published and states may adopt new limits and monitoring steps.

The full analysis

19 dimensions on this story — world impact, market read, and what happens next.

  • Full ContextLocked
  • Affected SectorsLocked
  • Stock ImpactLocked
  • Economic IndicatorLocked
  • Investor RelevanceLocked
  • Professional RelevanceLocked
  • Watch PointsLocked
  • Probability of ChangeLocked
  • Debate PointsLocked
  • Follow-up QuestionsLocked
  • Pros & ConsLocked
Read free — no credit card